Prognostic factors of grade 4 IDH-mutant astrocytoma

被引：0
|
作者：
Maqbool, Muhammad Asad [1 ]
Jenkins, Robert B. [1 ]
Ida, Cristiane M. [1 ]
Burns, Terry C. [1 ]
Kizilbash, Sani Haider [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14019
引用
收藏
页数：1
相关论文
共 50 条
  • [21] MIDLINE INVOLVEMENT IS ASSOCIATED WITH ABERRANT RB1 SIGNALING IN PATIENTS WITH GRADE 4 IDH-MUTANT ASTROCYTOMA
    Maqbool, Muhammad Asad
    Jenkins, Robert B.
    Ida, Cristiane M.
    Burns, Terence C.
    Kizilbash, Sani H.
    NEURO-ONCOLOGY, 2024, 26
  • [22] Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis
    Kwanghoon Lee
    Seong-Ik Kim
    Eric Eunshik Kim
    Yu-Mi Shim
    Jae-Kyung Won
    Chul-Kee Park
    Seung Hong Choi
    Hongseok Yun
    Hyunju Lee
    Sung-Hye Park
    Scientific Reports, 13
  • [23] PROGNOSTIC FACTORS, RESPONSE TO TREATMENT, AND OUTCOME OF PATIENTS WITH ISOCITRATE DEHYDROGENASE (IDH)-MUTANT ASTROCYTOMA, CNS WHO GRADE 4
    Weller, Michael
    Felsberg, Joerg
    Hentschel, Bettina
    Gramatzki, Dorothee
    Kubon, Nadezhda
    Wolter, Marietta
    Roth, Patrick
    Krex, Dietmar
    Herrlinger, Ulrich
    Westphal, Manfred
    Tonn, Joerg-Christian
    Regli, Luca
    Maurage, Claude-Alain
    von Deimling, Andreas
    Pietsch, Torsten
    Le Rhun, Emilie
    Reifenberger, Guido
    NEURO-ONCOLOGY, 2023, 25
  • [24] A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level
    Qi Liu
    Kuanyu Wang
    Ruoyu Huang
    Xuezhi Tong
    Tao Jiang
    Jiangfei Wang
    Pei Yang
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 579 - 591
  • [25] IDH-mutant grade 4 astrocytoma: a comparison integrating the clinical, pathological, and survival features between primary and secondary patients
    Liu, Yanwei
    Gao, Dezhi
    Chen, Huiyuan
    Zhang, Jing
    Yao, Kun
    Wu, Chenxing
    Li, Shouwei
    Yan, Wei
    Qiu, Xiaoguang
    JOURNAL OF NEUROSURGERY, 2024, 140 (01) : 94 - 103
  • [26] A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level
    Liu, Qi
    Wang, Kuanyu
    Huang, Ruoyu
    Tong, Xuezhi
    Jiang, Tao
    Wang, Jiangfei
    Yang, Pei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 579 - 591
  • [27] Astrocytoma, IDH-mutant, CNS WHO grade 3 with novel non-canonical IDH2 mutation
    Auen, T.
    Shonka, N.
    Chen, J.
    Cathcart, S.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 498 - 499
  • [28] Genomic features of IDH-mutant adult diffuse astrocytoma.
    Zhang, Hongjun
    Duan, Qianqian
    Zhang, Qin
    Tan, Yuan
    Sun, Tingting
    Qi, Chuang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] THE ROLE OF NONCODING RNAS IN THE PROGRESSION OF IDH-MUTANT ASTROCYTOMAS TO GRADE 4
    Hartewig, A.
    Jaatinen, S.
    Annala, M.
    Helen, P.
    Haapasalo, J.
    Zhang, W.
    Haapasalo, H.
    Nykter, M.
    Rautajoki, K. J.
    NEURO-ONCOLOGY, 2023, 25
  • [30] Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
    Yamaguchi, Junya
    Ohka, Fumiharu
    Seki, Masafumi
    Motomura, Kazuya
    Deguchi, Shoichi
    Shiba, Yoshiki
    Okumura, Yuka
    Kibe, Yuji
    Shimizu, Hiroki
    Maeda, Sachi
    Takido, Yuhei
    Yamamoto, Ryo
    Nakamura, Akihiro
    Karube, Kennosuke
    Saito, Ryuta
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
12345